XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Condensed Statements of Operations and Comprehensive (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues $ 2,151 $ 52,049
Cost of goods sold 3,446 55,134
Gross loss (1,295) (3,085)
Research and development expenses 42 36
Selling, general and administrative expenses 10,786 7,306
Operating loss (12,123) (10,427)
Interest expense    
Interest rate expense 7,078 4,435
Debt related fees and amortization expense 1,969 1,826
Accretion and other expenses of Series A preferred units 5,564 1,640
Other income (76) (41)
Loss before income taxes (26,658) (18,287)
Income tax expense (benefit) (248) 7
Net loss (26,410) (18,294)
Other comprehensive loss    
Foreign currency translation gain (loss) 117 (194)
Comprehensive loss $ (26,293) $ (18,488)
Net loss per common share    
Basic (in dollars per share) $ (0.73) $ (0.54)
Diluted (in dollars per share) $ (0.73) $ (0.54)
Weighted average shares outstanding    
Basic (in shares) 36,425 33,714
Diluted (in shares) 36,425 33,714